Cohance’s scientific and technological prowess sets us apart as a leader in the CDMO industry. Our innovation-driven approach leverages advanced technologies and deep expertise to deliver differentiated solutions:
Advanced Chemistries
Expertise in flow chemistry, high-pressure reactions, cryogenics, and chiral synthesis.
Next-Gen Platforms
Specialized capabilities in ADCs, oligonucleotides, and high-potency APIs.
R&D Excellence
State-of-the-art R&D centers, including Genome Valley (Hyderabad), NJ Bio (Princeton, US) and Sapala Organics (Hyderabad), equipped with cutting-edge tools like 400 MHz NMR, HPLC, and flow chemistry reactors.
R&D Highlights
Proven Track Record
- 34+ years of CDMO expertise delivering innovation across phases and geographies.
- 1,000+ projects successfully delivered with deep therapeutic area coverage.
- > 90% On-Time, In-Full (OTIF) performance ensuring reliability and trust.
Scientific Depth & Talent
- 400+ scientists, including 100+ dedicated to process R&D.
- 15+ years of average experience in process R&D and scale-up across our scientific team.
- > 15%+ of our scientists are PhD-qualified, bringing deep scientific expertise to every project.
Infrastructure & Capabilities
- 3 fully equipped R&D centers, strategically located for lab-to-plant continuity.
- 250+ unique chemistries and 300+ synthetic routes developed, from simple syntheses to complex, multi-step processes.
- 120+ optimized routes for yield, cost-efficiency, and sustainability.
- 150+ non-GMP and 400+ cGMP projects executed across Phases I–III.
Innovation-Driven Delivery
- Strong expertise in complex scale-up, bridging science and execution.
- Problem-solving mindset to address advanced chemistry challenges.
- Full lifecycle support, from development to commercialization.